Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.

Zhu B, Wei XX, Wang TB, Zhou YC, Liu AM, Zhang GW.

Arch Virol. 2015 Aug;160(8):2043-50. doi: 10.1007/s00705-015-2474-3. Epub 2015 Jun 13.

PMID:
26071245
2.

Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.

Yang Q, Fu S, Wang J.

Arch Virol. 2014 Nov;159(11):2997-3003. doi: 10.1007/s00705-014-2167-3. Epub 2014 Jul 10.

PMID:
25008898
3.

MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.

Gelley F, Zadori G, Nemes B, Fassan M, Lendvai G, Sarvary E, Doros A, Gerlei Z, Nagy P, Schaff Z, Kiss A.

J Gastroenterol Hepatol. 2014 Jan;29(1):121-7. doi: 10.1111/jgh.12362.

PMID:
24033414
4.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

5.

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP.

Lab Invest. 2010 Dec;90(12):1727-36. doi: 10.1038/labinvest.2010.126. Epub 2010 Jul 12.

6.

Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit.

He X, Zhang K, Gao X, Li L, Tan H, Chen J, Zhou Y.

Heart Vessels. 2016 Oct;31(10):1696-708. doi: 10.1007/s00380-016-0808-z. Epub 2016 Mar 11.

7.

MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.

Song LY, Ma YT, Wu CF, Wang CJ, Fang WJ, Liu SK.

Biomed Res Int. 2017;2017:1945631. doi: 10.1155/2017/1945631. Epub 2017 Aug 27.

8.

miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.

Wang JY, Gao YB, Zhang N, Zou DW, Wang P, Zhu ZY, Li JY, Zhou SN, Wang SC, Wang YY, Yang JK.

Mol Cell Endocrinol. 2014 Jul 5;392(1-2):163-72. doi: 10.1016/j.mce.2014.05.018. Epub 2014 Jun 2.

PMID:
24887517
9.

Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Zhang F, Sodroski C, Cha H, Li Q, Liang TJ.

Gastroenterology. 2017 Jan;152(1):257-270.e7. doi: 10.1053/j.gastro.2016.09.033. Epub 2016 Sep 30.

10.

Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.

He CL, Liu M, Tan ZX, Hu YJ, Zhang QY, Kuang XM, Kong WL, Mao Q.

World J Gastroenterol. 2018 Jan 14;24(2):226-236. doi: 10.3748/wjg.v24.i2.226.

11.

Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.

Liu N, Jiao T, Huang Y, Liu W, Li Z, Ye X.

J Virol. 2015 Mar;89(5):2739-49. doi: 10.1128/JVI.02784-14. Epub 2014 Dec 24.

12.

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.

Yang D, Meng X, Xue B, Liu N, Wang X, Zhu H.

PLoS One. 2014 Apr 11;9(4):e94501. doi: 10.1371/journal.pone.0094501. eCollection 2014.

13.

MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.

Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, Liu X, Li W, Yang C, Jiao B, Schaefer EA, Fusco DN, Salloum S, Chen L, Lin W, Chung RT.

J Virol. 2018 Mar 14;92(7). pii: e02009-17. doi: 10.1128/JVI.02009-17. Print 2018 Apr 1.

14.

miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling.

Tian H, He Z.

Yonsei Med J. 2018 Jun;59(4):511-518. doi: 10.3349/ymj.2018.59.4.511.

15.

Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW.

Am J Pathol. 2002 Feb;160(2):641-54.

16.

LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.

Fu N, Zhao SX, Kong LB, Du JH, Ren WG, Han F, Zhang QS, Li WC, Cui P, Wang RQ, Zhang YG, Nan YM.

Gene. 2017 Jun 30;618:1-7. doi: 10.1016/j.gene.2017.03.008. Epub 2017 Mar 14.

PMID:
28302418
17.

Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway.

Wang H, Gao H, Duan S, Song X.

Virus Res. 2015 Oct 2;208:7-12. doi: 10.1016/j.virusres.2015.05.002. Epub 2015 May 29.

PMID:
26027911
18.

Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.

Boštjančič E, Bandelj E, Luzar B, Poljak M, Glavač D.

J Viral Hepat. 2015 Feb;22(2):146-57. doi: 10.1111/jvh.12266. Epub 2014 Jul 25.

PMID:
25065618
19.

Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis.

Singaravelu R, Chen R, Lyn RK, Jones DM, O'Hara S, Rouleau Y, Cheng J, Srinivasan P, Nasheri N, Russell RS, Tyrrell DL, Pezacki JP.

Hepatology. 2014 Jan;59(1):98-108. doi: 10.1002/hep.26634. Epub 2013 Nov 19.

PMID:
23897856
20.

Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5.

Gong W, Guo X, Zhang Y.

Yonsei Med J. 2018 Dec;59(10):1181-1189. doi: 10.3349/ymj.2018.59.10.1181.

Supplemental Content

Support Center